Lewes, DE -- (SBWire) -- 12/27/2018 --Global Hyperimmune Globulins market will register a 9.7% CAGR in terms of revenue, reach US$ 1960 million by 2023, from US$ 1120 million in 2017.
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc.
Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
In the last several years, global market of Hyperimmune Globulins developed rapidly, with an average growth rate of 6%. In 2017, global revenue of Hyperimmune Globulins is nearly 1150 million USD; the actual production is about 40 million units.
The classification includes the Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins and others, and the proportion of Rabies Immunoglobulins in 2017 is about 44.2%, with the largest market share.
Hyperimmune Globulins is widely used in Government Institutions, Private Sector and Other. The most proportion of Hyperimmune Globulins is sold in Government Institutions, and the proportion in 2017 is about 62.7%.
Over the next five years, study projects that Hyperimmune Globulins will register a 9.7% CAGR in terms of revenue, reach US$ 1960 million by 2023, from US$ 1120 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Hyperimmune Globulins market by product type, application, key manufacturers and key regions.
To calculate the market size, study considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others
Segmentation by application:
Government Institutions
Private Sector
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hyperimmune Globulins consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Hyperimmune Globulins market by identifying its various subsegments.
Focuses on the key global Hyperimmune Globulins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hyperimmune Globulins with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hyperimmune Globulins submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Spanning over 166 pages "Forecast of Global Hyperimmune Globulins Consumption Market 2023" report covers Scope of the Report, Executive Summary, Global Hyperimmune Globulins by Players, Hyperimmune Globulins by Regions, Market Drivers, Challenges and Trends, Marketing, Distributors and Customer, Global Hyperimmune Globulins Market Forecast, Key Players Analysis, Research Findings and Conclusion.
Please visit this link for more details: https://www.marketresearchreports.com/mrrpb2/forecast-global-hyperimmune-globulins-consumption-market-2023
Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare
For related reports please visit: https://www.marketresearchreports.com/search/site/Hyperimmune%20Globulin
Read our Interactive Market Research Blog
About MarketResearchReports.com
MarketResearchReports.com is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.
Contact us for your market research requirements: https://www.marketresearchreports.com/contact
